Healthcare - Biotechnology - NASDAQ - US
$ 44.5
-3.8 %
$ 2.12 B
Market Cap
-19.26
P/E
BALANCE SHEET
647 M
ASSETS
398 M
LIABILITIES
249 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Mirum Pharmaceuticals, Inc.
| Current Assets | 388 M |
| Cash & Short-Term Investments | 286 M |
| Receivables | 68 M |
| Other Current Assets | 33.2 M |
| Non-Current Assets | 259 M |
| Long-Term Investments | 0 |
| PP&E | 1.99 M |
| Other Non-Current Assets | 257 M |
| Current Liabilities | 87.1 M |
| Accounts Payable | 7.42 M |
| Short-Term Debt | 2.21 M |
| Other Current Liabilities | 77.4 M |
| Non-Current Liabilities | 311 M |
| Long-Term Debt | 307 M |
| Other Non-Current Liabilities | 3.85 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 286.3 | 28.0 | 31.3 | 142.1 | 140.0 | 52.0 |
| Short Term Investments | 0 | 123.7 | 125.2 | 89.7 | 104.7 | 0 |
| Receivables | 68.0 | 24.0 | 3.3 | 0 | 0 | 0 |
| Inventory | 22.3 | 5.6 | 1.5 | 0 | 0 | 0 |
| Other Current Assets | 10.9 | 8.9 | 10.5 | 9.1 | 5.4 | 24 K |
| Total Current Assets | 387.5 | 190.2 | 166.6 | 236.3 | 119.4 | 52.0 |
| PP&E | 2.0 | 2.3 | 2.5 | 3.2 | 3.7 | 0 |
| Intangible Assets | 252.9 | 59.0 | 18.7 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 100.0 | 5.0 | 0 | 23.3 | 0 |
| Other Long Term Assets | 4.2 | 101.4 | 101.8 | 1.3 | 0.3 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 646.6 | 352.9 | 294.7 | 240.9 | 146.7 | 52.0 |
| LIABILITIES | ||||||
| Accounts Payable | 7.4 | 8.7 | 9.2 | 3.2 | 3.4 | 0.3 |
| Short Term Debt | 2.2 | 1.9 | 1.4 | 1.3 | 0.8 | 0 |
| Other Current Liabilities | 77.4 | 54.2 | 32.0 | 14.0 | 8.9 | 2.2 |
| Total Current Liabilities | 87.1 | 64.7 | 42.6 | 18.5 | 13.1 | 2.4 |
| Long Term Debt | 307.0 | 2.5 | 3.8 | 5.3 | 6.5 | 0 |
| Deferred Tax Income | 0 | (140.4) | (129.9) | (47.7) | 0 | 0 |
| Other Liabilities | 3.8 | 143.6 | 128.0 | 45.1 | (3.2) | 59.8 |
| Total Liabilities | 398.0 | 210.9 | 174.4 | 68.8 | 16.4 | 62.3 |
| EQUITY | ||||||
| Common Stock | 5 K | 4 K | 3 K | 3 K | 2 K | 7.0 |
| Retained Earnings | (556.2) | (392.8) | (257.2) | (173.2) | (69.9) | (17.3) |
| Other Accumulative Comprehensive Income/Loss | 1.6 | (0.2) | 35 K | 83 K | 0.1 | (66.8) |
| Total Equity | 248.7 | (392.8) | 120.2 | (173.2) | (69.9) | (10.3) |
| Total Liabilities and Equity | 646.6 | (182.0) | 294.7 | (104.4) | (53.5) | 52.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 40.9 | 33.8 | 30.3 | 25.3 | 23.0 | 23.0 |